| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL0900038 | 注射用重组人血清白蛋白/粒细胞刺激因子融合蛋白 | Lyophilized | Biological Products(1) | New Drug Application | 2009-12-18 | 天津溥瀛生物技术有限公司 | Tianjin PuYing Biotechnology Co Ltd | Certificate Issued | 2011-11-07 | view | |
| CXSB1900023 | 注射用重组人血清白蛋白/粒细胞刺激因子融合蛋白 | Lyophilized | Biological Products | Supplementary Application | 2019-09-24 | 中美福源生物技术（北京）股份有限公司 | Fortune Rock (China) Co Ltd | In Review | 2019-09-23 | view |